ANGO vs HCA · rev $292.5M vs P/E 17, rev $75.60B
AngioDynamics Inc (ANGO) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
ANGO currently screens at market cap $378.5M. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the ANGO and HCA stock pages for the full models.
Not investment advice.